IV plerixafor combined with G-CSF is highly effective for stem cell mobilization in lymphoma patients undergoing autologous stem cell collection

被引：0
作者：
Cashen, A. [1 ]
Rettig, M. [1 ]
Gao, F. [1 ]
Reineck, T. [1 ]
Abboud, C. [1 ]
Stockerl-Goldstein, K. [1 ]
Vij, R. [1 ]
Uy, G. [1 ]
Westervelt, P. [1 ]
DiPersio, J. [1 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S33 / S33
页数：1
相关论文
共 50 条
  • [41] G-CSF BIOSIMILAR (ZARZIO®) MOBILIZATION FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
    Zabalza, A.
    Anton, P.
    Antelo, M.
    Zalba, S.
    Aznar, M.
    Vicente, E.
    Aoiz, I.
    Olavarria, E.
    HAEMATOLOGICA, 2013, 98 : 667 - 667
  • [42] Comparing Cyclophosphamide with G-CSF and Plerixafor with G-CSF As Stem Cell Mobilization (SCM) Regimens for Multiple Myeloma (MM) Patients: An Evaluation of Mobilization Efficacy and Toxicity
    Tan, Carlyn Rose C.
    Pancari, Philip A.
    Ulicny, John
    Martin, Mary Ellen
    Barta, Stefan Klaus
    Kropf, Patricia Lamont
    Fung, Henry C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S136 - S136
  • [43] Spontaneous splenic rupture following stem cell mobilization with G-CSF and plerixafor in AL amyloidosis
    Lessi, Federica
    Marson, Piero
    Colpo, Anna
    Marino, Filippo
    Branca, Antonio
    Tison, Tiziana
    Adami, Fausto
    TRANSFUSION AND APHERESIS SCIENCE, 2016, 54 (02) : 256 - 258
  • [44] G-CSF Plus Preemptive Plerixafor Versus Cyclophosphamide Plus G-CSF for Autologous Stem Cell Mobilization in Multiple Myeloma: Effectiveness, Safety and Cost Analysis
    Antar, Ahmad
    Otrock, Zaher
    Kharfan-Dabaja, Mohamed
    Abou Ghaddara, Hussein
    Kreidieh, Nabila
    Mahfouz, Rami
    Bazarbachi, Ali
    BLOOD, 2014, 124 (21)
  • [45] CYCLOPHOSPHAMIDE OR PLERIXAFOR AND G-CSF STEM CELL MOBILIZATION (SCM): INITIAL COST COMPARISON ANALYSIS
    Jagasia, M. H.
    Pickard, S.
    Chen, H.
    Dixon, S.
    Savani, B. N.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S202 - S203
  • [46] Successful Hematopoietic Stem Cell Collection in Patients Who Fail Initial Plerixafor Mobilization for Autologous Stem Cell Transplant
    Veeraputhiran, Muthu
    Jain, Tania
    Cronin, Simon
    Al-Kadhimi, Zaid
    Abidi, Muneer H.
    Ayash, Lois
    Mellert, Kendra
    Lum, Lawrence G.
    Ratanatharathorn, Voravit
    Uberti, Joseph P.
    Deol, Abhinav
    JOURNAL OF CLINICAL APHERESIS, 2014, 29 (06) : 293 - 298
  • [47] Hematopoietic, Immune Recovery and Outcomes after Autologous Stem Cell Transplantation Following Plerixafor Plus G-CSF Versus Chemotherapy and G-CSF Based Mobilization in Pediatric Patients
    Choi, Jung Yoon
    Kang, Hyoung Jin
    Hong, Kyung Taek
    Hong, Che Ry
    Park, Kyung Duk
    Shin, Hee Young
    BLOOD, 2017, 130
  • [48] Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone
    Sung, A. D.
    Grima, D. T.
    Bernard, L. M.
    Brown, S.
    Carrum, G.
    Holmberg, L.
    Horwitz, M. E.
    Liesveld, J. L.
    Kanda, J.
    McClune, B.
    Shaughnessy, P.
    Tricot, G. J.
    Chao, N. J.
    BONE MARROW TRANSPLANTATION, 2013, 48 (11) : 1444 - 1449
  • [49] Autophagy is required for stem cell mobilization by G-CSF
    Leveque-El Mouttie, Lucie
    Vu, Therese
    Lineburg, Katie E.
    Kuns, Rachel D.
    Bagger, Frederik O.
    Teal, Bianca E.
    Lor, Mary
    Boyle, Glen M.
    Bruedigam, Claudia
    Mintern, Justine D.
    Hill, Geoffrey R.
    MacDonald, Kelli P. A.
    Lane, Steven W.
    BLOOD, 2015, 125 (19) : 2933 - 2936
  • [50] Autologous Stem Cell Mobilization in the Age of Plerixafor
    Cooper, Dennis L.
    Medoff, Erin
    Patel, Natalie
    Baker, Julie
    Pratt, Kathryn
    Foss, Francine
    Seropian, Stuart E.
    Perreault, Sarah
    Wu, Yanyun
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (07) : 411 - 416
12345